Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
Sponsor: Aage Bangs Fond
Listed as NCT01356758, this observational or N/A phase trial focuses on Atherosclerosis and Atopic Dermatitis and remains completed. Sponsored by Aage Bangs Fond, it has been updated 10 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aage Bangs Fond
- Aarhus University Hospital
- AbbVie
- Region Midt Forskningsfond
- University of Aarhus
For direct contact, visit the study record on ClinicalTrials.gov .